Maze Therapeutics, Inc. Made Big Gain
Thu, Sep 11, 2025 at 07:27 PM
Maze Therapeutics, Inc. (MAZE:NASDAQ) rocketted at $24.8, representing a gain of 54.8%. On Thu, Sep 11, 2025, MAZE:NASDAQ touched a New 2-Week High of $24.8. The stock appeared on our News Catalysts scanner on Thu, Sep 11, 2025 at 09:24 AM in the 'BIOTECH' category. From Thu, Aug 28, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
About Maze Therapeutics, Inc. (MAZE:NASDAQ)
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,...
Top 10 Gainers:
- Next Technology Holding Inc. (NXTT:NASDAQ), 97.22%
- Vince Holding Corp. (VNCE:NYSE), 89.16%
- MOGU Inc. (MOGU:NYSE), 84.4%
- Opendoor Technologies Inc. (OPEN:NASDAQ), 79.52%
- reAlpha Tech Corp. (AIRE:NASDAQ), 75.71%
- Profusa Inc. (PFSA:NASDAQ), 74.04%
- Wearable Devices Ltd. (WLDS:NASDAQ), 56.56%
- Alset Inc. (AEI:NASDAQ), 56.3%
- Maze Therapeutics, Inc. (MAZE:NASDAQ), 54.81%
- New Era Energy & Digital Inc Com (NUAI:NASDAQ), 47.95%